NCBiotech News

We work hard to bring you news about North Carolina’s wide-ranging life sciences community. Please feel free to share it with others. And let us know if you have something we should know about.

This week leaders in the life sciences are gathering in Raleigh for US Biostimulants Summit 2023. The event will concentrate on the biostimulant industry’s focus on increasing crop yields and protecting plant growth.

The small team at Raleigh-based startup, Collaborations Pharmaceuticals, spends the bulk of its time looking for safe and effective molecules that can be developed into drugs to treat rare and infectious diseases.

Opus Genetics, a Research Triangle Park drug development startup focused on inherited diseases of the retina, has raised an additional $4.5 million in funding from investors.Opus Genetics logo

Cereius, Inc., a biotechnology company developing therapies to treat cancer that has spread to the brain, has been acquired by San Diego-based Solve Therapeutics, Inc. (SolveTx).

WINSTON-SALEM - Salem Academy and College has placed a high priority on STEM education in recent years, helping more women and girls develop and deploy their skills in science, technology, engineering and mathematics. 

So it’s only fitting that NASA - sitting at the forefront of science and technology - has taken notice. The space agency has awarded Salem Academy and College a three-year grant worth nearly $750,000 to attract and retain women in STEM degree programs and careers. 

Medical device startup restor3d, which uses 3D printing for a more individualized approach to implant surgery, is getting bigger.

The Durham-headquartered company has entered into a definitive merger agreement with Conformis, Inc. to acquire all outstanding shares of common stock of the Massachusetts-based business for $2.27 per share. The all-cash deal is a 96% premium to Conformis’ closing price on June 22. It should be completed by the end of the third quarter of this year.

KaryoLogic, a karyotyping services company based in Durham, is teaming up with a French biotechnology company to test and analyze chromosomes in human stem cells.

The partnership with Stem Genomics of Montpellier, France, will allow KaryoLogic to offer a digital assay that can identify more than 90% of the most common genomic abnormalities found in human pluripotent stem cells, according to KaryoLogic.

Back in 2018, walking away from a conversation with North Pitt High School sophomore Diana De Leon, Mark Phillips knew he wanted to help her. He just needed to figure out how. 

Mark is North Carolina Biotechnology Center’s Vice President of Statewide Operations and Executive Director of its Eastern Regional Office in the public power city of Greenville, North Carolina. 

Research Triangle Park-based AgBiome has tapped Ginkgo Bioworks to help it accelerate the development of new agricultural biologicals and improve existing products used in crop protection.

The North Carolina Biotechnology Center and a host of partners showcased the strengths of North Carolina’s life sciences community at BIO 2023, the international biotechnology conference in Boston last week.  

ProKidney LLC, a Winston-Salem-based clinical-stage biotechnology company founded in 2015 and targeting chronic kidney disease (CKD) with a proprietary cell therapy, plans to create up to 330 jobs and establish a new manufacturing facility in Greensboro by 2027. 

East Carolina University’s annual Spring Pharma Conference proved personal for Jack Pender.

“This is a meeting of my pharma friends,” said Pender, director of pharmaceutical training and laboratory services in the ECU Department of Chemistry.

Pender provided opening remarks at the event that drew more than 130 pharmaceutical industry representatives and employees from 49 pharmaceutical and life sciences companies for two days of information, topical discussions, presentations, vendors and networking.

Local startups innovating in health care made important connections with leaders from health systems and payer organizations during the “Aligning Health Care Innovation in North Carolina: Health Systems, Payers, Innovators, and the Quintuple Aim,” event held on April 27. 

North Carolina Agricultural and Technical State University and Merck (NYSE:MRK) announced a collaboration agreement today for Merck to build a biotechnology training center at Gateway Research Park’s South Campus in East Greensboro.

Merck will outfit the facility with the equipment and classroom spaces necessary to provide and enhance academic programming and training for biotechnology careers for North Carolina A&T students. A process laboratory will allow opportunities for students to put knowledge into practice in an advanced discovery setting.

North Carolina Gov. Roy Cooper was recognized June 6 at the 20th annual World Stem Cell Summit in Winston-Salem for his role in developing the life sciences.

Cooper received the Regenerative Medicine Action Leadership Award from the Regenerative Medicine Foundation, a non-profit organization that promotes the development of regenerative medicine to improve health and deliver cures.

scroll back to top of page